Lymphangioma

7 registered clinical trials studyying Lymphangioma — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anoma NCT07477548	Yonsei University	Phase 2
Recruiting	A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations NCT05983159	Murdoch Childrens Research Institute	Phase 2
Recruiting	Institution of an Italian Registry and Biobank for Biological Sample Collection NCT06892964	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	N/A
Completed	Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma NCT06943703	National Children's Hospital, Vietnam	—
Completed	A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations NCT01290484	Stanford University	Phase 1 / Phase 2
Completed	Clinical Characteristics of Lymphatic Malformations NCT06257719	West China Hospital	—
No Longer Available	Compassionate Use of BYL 719 Alpelisib NCT03941782	New Mexico Cancer Research Alliance	—